Cargando…

Artificial intelligence for diabetic retinopathy in low-income and middle-income countries: a scoping review

Diabetic retinopathy (DR) is a leading cause of blindness globally. There is growing evidence to support the use of artificial intelligence (AI) in diabetic eye care, particularly for screening populations at risk of sight loss from DR in low-income and middle-income countries (LMICs) where resource...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cleland, Charles R, Rwiza, Justus, Evans, Jennifer R, Gordon, Iris, MacLeod, David, Burton, Matthew J, Bascaran, Covadonga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Emerging Technologies, Pharmacology and Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401245/ https://www.ncbi.nlm.nih.gov/pubmed/37532460 http://dx.doi.org/10.1136/bmjdrc-2023-003424

Ejemplares similares

Simple, Mobile-based Artificial Intelligence Algorithm in the detection of Diabetic Retinopathy (SMART) study
por: Sosale, Bhavana, et al.
Publicado: (2020)

Effectiveness of interventions to increase uptake and completion of treatment for diabetic retinopathy in low- and middle-income countries: a rapid review protocol
por: Bascaran, Covadonga, et al.
Publicado: (2021)

Effectiveness of task-shifting for the detection of diabetic retinopathy in low- and middle-income countries: a rapid review protocol
por: Bascaran, Covadonga, et al.
Publicado: (2021)

Defining measures of emergency care access in low-income and middle-income countries: a scoping review
por: Hirner, Sarah, et al.
Publicado: (2023)

Efficacy of intravitreal AFlibercept injection For Improvement of retinal Nonperfusion In diabeTic retinopathY (AFFINITY study)
por: Kim, Yoon Jeon, et al.
Publicado: (2020)

Performance of the FreeStyle Libre Flash glucose monitoring system in patients with type 1 and 2 diabetes mellitus
por: Fokkert, M J, et al.
Publicado: (2017)

Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study
por: Skyler, Jay S., et al.
Publicado: (2015)

Long-term lutein administration attenuates retinal inflammation and functional deficits in early diabetic retinopathy using the Ins2(Akita/+) mice
por: Wang, Wei, et al.
Publicado: (2020)

Rationale and Design of the Vitamin D and Type 2 Diabetes (D2d) Study: A Diabetes Prevention Trial
por: Pittas, Anastassios G., et al.
Publicado: (2014)

Effect of Repeated Glucagon Doses on Hepatic Glycogen in Type 1 Diabetes: Implications for a Bihormonal Closed-Loop System
por: Castle, Jessica R., et al.
Publicado: (2015)

Metabolic Effects of Exercise Training Among Fitness-Nonresponsive Patients With Type 2 Diabetes: The HART-D Study
por: Pandey, Ambarish, et al.
Publicado: (2015)

Restoring Insulin Secretion (RISE): Design of Studies of β-Cell Preservation in Prediabetes and Early Type 2 Diabetes Across the Life Span
Publicado: (2014)

Enhancement of Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes
por: Novak, Vera, et al.
Publicado: (2014)

Safety of Nighttime 2-Hour Suspension of Basal Insulin in Pump-Treated Type 1 Diabetes Even in the Absence of Low Glucose
por: Sherr, Jennifer L., et al.
Publicado: (2014)

Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
por: Orban, Tihamer, et al.
Publicado: (2014)

Acute Metabolic Effects of Exenatide in Patients With Type 1 Diabetes With and Without Residual Insulin to Oral and Intravenous Glucose Challenges
por: Ghazi, Tara, et al.
Publicado: (2014)

Overnight Glucose Control With an Automated, Unified Safety System in Children and Adolescents With Type 1 Diabetes at Diabetes Camp
por: Ly, Trang T., et al.
Publicado: (2014)

Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit
por: Kosiborod, Mikhail, et al.
Publicado: (2014)

B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results
por: Pescovitz, Mark D., et al.
Publicado: (2014)

Internet-delivered cognitive behaviour therapy for depression in people with diabetes: study protocol for a randomised controlled trial
por: Robins, Lisa, et al.
Publicado: (2015)

Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3–6 years: comparison between diluted and standard insulin strength
por: Elleri, Daniela, et al.
Publicado: (2014)

Vitamin D for the treatment of painful diabetic neuropathy
por: Basit, Abdul, et al.
Publicado: (2016)

Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes
por: Demeester, Simke, et al.
Publicado: (2015)

Inhaled Formoterol Diminishes Insulin-Induced Hypoglycemia in Type 1 Diabetes
por: Belfort-DeAguiar, Renata D., et al.
Publicado: (2015)

Energy Balance After Sodium–Glucose Cotransporter 2 Inhibition
por: Ferrannini, Giulia, et al.
Publicado: (2015)

Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled insulin
por: Levin, Philip A, et al.
Publicado: (2016)

Improved diabetes medication convenience and satisfaction in persons with type 2 diabetes after switching to insulin glargine 300 U/mL: results of the observational OPTIN-D study
por: Wieringa, Thomas H, et al.
Publicado: (2018)

Identification of Unique Antigenic Determinants in the Amino Terminus of IA-2 (ICA512) in Childhood and Adult Autoimmune Diabetes: New Biomarker Development
por: Acevedo-Calado, Maria, et al.
Publicado: (2017)

Artificial Intelligence for Plastic Surgeons
por: Sue, Gloria R.
Publicado: (2023)

Assistive technologies for ageing populations in six low-income and middle-income countries: a systematic review
por: Marasinghe, Keshini Madara, et al.
Publicado: (2015)

Is Artificial Intelligence the Cost-Saving Lens to Diabetic Retinopathy Screening in Low- and Middle-Income Countries?
por: Rizvi, Anza, et al.
Publicado: (2023)

Grading diabetic retinopathy: an introduction
por: Bascaran, Covadonga
Publicado: (2023)

Editorial: Challenges in implementing digital health in public health settings in low and middle income countries
por: Duggal, Mona, et al.
Publicado: (2023)

Multicenter, Head-to-Head, Real-World Validation Study of Seven Automated Artificial Intelligence Diabetic Retinopathy Screening Systems
por: Lee, Aaron Y., et al.
Publicado: (2021)

Update on the management of diabetes in long-term care facilities
por: Idrees, Thaer, et al.
Publicado: (2022)

Human Beauty according to Artificial Intelligence
por: Kenig, Nitzan, et al.
Publicado: (2023)

Toward Responsible Artificial Intelligence in Long-Term Care: A Scoping Review on Practical Approaches
por: Lukkien, Dirk R M, et al.
Publicado: (2021)

Bias in algorithms of AI systems developed for COVID-19: A scoping review
por: Delgado, Janet, et al.
Publicado: (2022)

Artificial intelligence for strengthening healthcare systems in low- and middle-income countries: a systematic scoping review
por: Ciecierski-Holmes, Tadeusz, et al.
Publicado: (2022)

Key considerations when choosing a retinal camera for diabetic retinopathy screening
por: Bascaran, Covadonga
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g9snh44an3ln3bib0nkge0fv3e